CD4 and myeloid sarcoma: Autoreactive CD4+ T cells have been observed in similar or higher numbers in MS patients' peripheral blood compared to healthy individuals [61, 62] and several publications advocate that myelin-specific T cells obtained from MS patients display altered characteristics compared to those detected in healthy donors.